Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1996 Nov 23;313(7068):1273–1274. doi: 10.1136/bmj.313.7068.1273

Lipids and secondary prevention of ischaemic heart disease.

C D Byrne, S H Wild
PMCID: PMC2352730  PMID: 8942680

Full text

PDF
1273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong A., Duncan B., Oliver M. F., Julian D. G., Donald K. W., Fulton M., Lutz W., Morrison S. L. Natural history of acute coronary heart attacks. A community study. Br Heart J. 1972 Jan;34(1):67–80. doi: 10.1136/hrt.34.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996 Aug 15;335(7):453–461. doi: 10.1056/NEJM199608153350701. [DOI] [PubMed] [Google Scholar]
  3. Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979 Jan;90(1):85–91. doi: 10.7326/0003-4819-90-1-85. [DOI] [PubMed] [Google Scholar]
  4. Pedersen T. R., Kjekshus J., Berg K., Olsson A. G., Wilhelmsen L., Wedel H., Pyörälä K., Miettinen T., Haghfelt T., Faergeman O. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation. 1996 May 15;93(10):1796–1802. doi: 10.1161/01.cir.93.10.1796. [DOI] [PubMed] [Google Scholar]
  5. Pharoah P. D., Hollingworth W. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population. BMJ. 1996 Jun 8;312(7044):1443–1448. doi: 10.1136/bmj.312.7044.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rose G., Hamilton P. S., Keen H., Reid D. D., McCartney P., Jarrett R. J. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet. 1977 Jan 15;1(8003):105–109. doi: 10.1016/s0140-6736(77)91701-9. [DOI] [PubMed] [Google Scholar]
  7. Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M., Wun C. C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3;335(14):1001–1009. doi: 10.1056/NEJM199610033351401. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES